v3.25.2
NET INCOME PER SHARE OF COMMON STOCK
6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
NET INCOME PER SHARE OF COMMON STOCK NET INCOME PER SHARE OF COMMON STOCK
The Company is required to utilize the “two-class” method of computing basic and diluted net income per share because the Company issued certain PIPRs, including certain P-PIPRs, which are treated as participating securities.
The Company’s basic and diluted net income per share calculations using the “two-class” method for the three month and six month periods ended June 30, 2025 and 2024 are presented below:
Three Months Ended
June 30,
Six Months Ended
June 30,
2025202420252024
Net income attributable to Lazard$55,346 $49,909 $115,721 $85,664 
Adjustment for earnings attributable to participating securities(904)(873)(2,713)(2,152)
Net income attributable to Lazard - basic54,442 49,036 113,008 83,512 
Adjustment for earnings attributable to participating securities– 206 – 401 
Net income attributable to Lazard - diluted$54,442 $49,242 $113,008 $83,913 
Weighted average number of shares of common stock outstanding94,242,23190,172,32592,776,70989,360,041
Weighted average number of shares of common stock issuable on a non-contingent basis3,292,0882,714,0393,618,1622,713,373
Weighted average number of shares of common stock outstanding - basic97,534,31992,886,36496,394,87192,073,414
Weighted average number of incremental shares of common stock issuable from share-based incentive compensation (a)7,377,3147,741,5038,475,3227,916,403
Weighted average number of shares of common stock outstanding - diluted104,911,633 100,627,867 104,870,193 99,989,817 
Net income attributable to Lazard per share of common stock:
Basic$0.56 $0.53 $1.17 $0.91 
Diluted$0.52 $0.49 $1.08 $0.84 
__________________________________
(a)The aggregate weighted average number of incremental shares of common stock issuable from PIPRs for the three month and six month periods ended June 30, 2025 of 1,570,105 and 2,192,413, respectively, and for the three month and six month periods ended June 30, 2024 of 1,229,021 and 1,698,271, respectively, that could be potentially dilutive in future periods, have been excluded from the computation of diluted net income per share as the effect would be antidilutive in the respective periods.